A Phase I Trial And Pharmacokinetic (Pk) Study Of Vorinostat (Saha) In Combination With 13 Cis-Retinoic Acid (13cra) In Children With Refractory Neuroblastomas, Medulloblastomas, Primitive Neuroectodermal Tumors (Pnets), And Atypical Teratoid Rhabdoid Tumor

JOURNAL OF CLINICAL ONCOLOGY(2008)

引用 3|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要